277 related articles for article (PubMed ID: 16229821)
1. Oct4 pseudogenes are transcribed in cancers.
Suo G; Han J; Wang X; Zhang J; Zhao Y; Zhao Y; Dai J
Biochem Biophys Res Commun; 2005 Dec; 337(4):1047-51. PubMed ID: 16229821
[TBL] [Abstract][Full Text] [Related]
2. Stem cell regulatory function mediated by expression of a novel mouse Oct4 pseudogene.
Lin H; Shabbir A; Molnar M; Lee T
Biochem Biophys Res Commun; 2007 Mar; 355(1):111-6. PubMed ID: 17280643
[TBL] [Abstract][Full Text] [Related]
3. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research.
Liedtke S; Stephan M; Kögler G
Biol Chem; 2008 Jul; 389(7):845-50. PubMed ID: 18627312
[TBL] [Abstract][Full Text] [Related]
4. Expression of OCT4 pseudogenes in human tumours: lessons from glioma and breast carcinoma.
Zhao S; Yuan Q; Hao H; Guo Y; Liu S; Zhang Y; Wang J; Liu H; Wang F; Liu K; Ling EA; Hao A
J Pathol; 2011 Apr; 223(5):672-82. PubMed ID: 21341266
[TBL] [Abstract][Full Text] [Related]
5. Absence of OCT4 expression in somatic tumor cell lines.
Cantz T; Key G; Bleidissel M; Gentile L; Han DW; Brenne A; Schöler HR
Stem Cells; 2008 Mar; 26(3):692-7. PubMed ID: 18032701
[TBL] [Abstract][Full Text] [Related]
6. OCT4 pseudogene 5 upregulates OCT4 expression to promote proliferation by competing with miR-145 in endometrial carcinoma.
Bai M; Yuan M; Liao H; Chen J; Xie B; Yan D; Xi X; Xu X; Zhang Z; Feng Y
Oncol Rep; 2015 Apr; 33(4):1745-52. PubMed ID: 25634023
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies.
Hoffmann MJ; Müller M; Engers R; Schulz WA
Biochem Pharmacol; 2006 Nov; 72(11):1577-88. PubMed ID: 16854382
[TBL] [Abstract][Full Text] [Related]
8. Implication of human OCT4 transactivation domains for self-regulatory transcription.
Lim HY; Do HJ; Lee WY; Kim DK; Seo HG; Chung HJ; Park JK; Chang WK; Kim JH; Kim JH
Biochem Biophys Res Commun; 2009 Jul; 385(2):148-53. PubMed ID: 19445899
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of the embryo/cancer gene ECSA(DPPA2), the cancer/testis gene BORIS and the pluripotency structural gene OCT4, in human preimplantation development.
Monk M; Hitchins M; Hawes S
Mol Hum Reprod; 2008 Jun; 14(6):347-55. PubMed ID: 18467432
[TBL] [Abstract][Full Text] [Related]
10. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis.
Hu T; Liu S; Breiter DR; Wang F; Tang Y; Sun S
Cancer Res; 2008 Aug; 68(16):6533-40. PubMed ID: 18701476
[TBL] [Abstract][Full Text] [Related]
11. Oct4 is expressed in human gliomas and promotes colony formation in glioma cells.
Du Z; Jia D; Liu S; Wang F; Li G; Zhang Y; Cao X; Ling EA; Hao A
Glia; 2009 May; 57(7):724-33. PubMed ID: 18985733
[TBL] [Abstract][Full Text] [Related]
12. Characterization of POU5F1 (OCT4) gene and its promoter in buffalo ESC-like cells identifies multiple transcription start sites and expression of four pseudogenes.
Singh N; George A; Sharma R; Singla SK; Palta P; Manik R; Chauhan MS; Singh D
Gene; 2012 Jan; 491(2):165-72. PubMed ID: 22019428
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of Oct4 variants and pseudogenes in normal urothelium and urothelial cancer.
Wezel F; Pearson J; Kirkwood LA; Southgate J
Am J Pathol; 2013 Oct; 183(4):1128-1136. PubMed ID: 23933063
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of human Oct4 by steroidogenic factor-1.
Yang HM; Do HJ; Kim DK; Park JK; Chang WK; Chung HM; Choi SY; Kim JH
J Cell Biochem; 2007 Aug; 101(5):1198-209. PubMed ID: 17226773
[TBL] [Abstract][Full Text] [Related]
15. Spermatogonial stem cell self-renewal requires OCT4, a factor downregulated during retinoic acid-induced differentiation.
Dann CT; Alvarado AL; Molyneux LA; Denard BS; Garbers DL; Porteus MH
Stem Cells; 2008 Nov; 26(11):2928-37. PubMed ID: 18719224
[TBL] [Abstract][Full Text] [Related]
16. Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma.
Wang L; Guo ZY; Zhang R; Xin B; Chen R; Zhao J; Wang T; Wen WH; Jia LT; Yao LB; Yang AG
Carcinogenesis; 2013 Aug; 34(8):1773-81. PubMed ID: 23615404
[TBL] [Abstract][Full Text] [Related]
17. Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomes.
Saha SK; Jeong Y; Cho S; Cho SG
Sci Rep; 2018 Oct; 8(1):14806. PubMed ID: 30287838
[TBL] [Abstract][Full Text] [Related]
18. OCT4 expression in human non-small cell lung cancer: implications for therapeutic intervention.
Karoubi G; Gugger M; Schmid R; Dutly A
Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):393-7. PubMed ID: 19126554
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA.
Scarola M; Comisso E; Pascolo R; Chiaradia R; Marion RM; Schneider C; Blasco MA; Schoeftner S; Benetti R
Nat Commun; 2015 Jul; 6():7631. PubMed ID: 26158551
[TBL] [Abstract][Full Text] [Related]
20. Silencing the OCT4-PG1 pseudogene reduces OCT-4 protein levels and changes characteristics of the multidrug resistance phenotype in chronic myeloid leukemia.
Lettnin AP; Wagner EF; Carrett-Dias M; Dos Santos Machado K; Werhli A; Cañedo AD; Trindade GS; de Souza Votto AP
Mol Biol Rep; 2019 Apr; 46(2):1873-1884. PubMed ID: 30721421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
